Shares of Spyre Therapeutics (SYRE) have gained 0.9% over the past four weeks to close the last trading session at $22.65, but there could still be a solid upside left in the stock if short-term ...

The firm increased its portfolio allocation in SYRE by 3,677.71% over the last quarter. VR Adviser holds 2,373K shares representing 6.48% ownership of the company. Rtw Investments holds 2,233K ...

Wolfe Research assumed coverage on shares of Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) in a research report issued ...

Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) is projected to post its quarterly earnings results before the market opens on Thursday, March 6th.Analysts expect Spyre Therapeutics to post ...

NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ: SYRE). Such investors are ...

As a Black, queer, transmasculine, gender expansive, polyamorous, and kinky healing practitioner Syre (he/him) is passionate about working with those who are traditionally marginalized ...

During discussions with the Ministry of Industry and Trade, Syre Group outlined its intention to develop a high-tech fabric production complex in Nhon Hoi A Industrial Park, Binh Dinh province.

In a bid to support Europe’s circular economy policies such as the Ecodesign for Sustainable Products Regulation (ESPR), ...